KEY TAKEAWAYS FROM THE CDDF WEBINAR – REGULATORY CONSIDERATIONS FOR IMMUNOTHERAPY & RADIOTHERAPY COMBINATIONS
[READ KEY TAKEAWAYS FROM THE CDDF WEBINAR] The Cancer Drug Development Forum (CDDF) held a live webinar on the topic of regulatory considerations for Immunotherapy and Radiotherapy Combinations on Monday 27 February 2023. Here are the key takeaways from Prof Paz...
Interviews with the CDDF’s Key Stakeholders
The Cancer Drug Development Forum (CDDF) greatly values all stakeholders’ voices and engagement which help the oncology community break down silos and continue open, meaningful dialogue. To accelerate oncology drug development and deliver optimal treatment to cancer...
CDDF Annual Conference 2023: Executive Summary
📢 The Cancer Drug Development Forum (CDDF) is delighted to inform you that its executive summary of the Annual Conference 2023 has been published and is available to all our stakeholders. The 2023 edition of the multi-stakeholder conference took place on 6-8 February...
CDDF Annual Conference – Day 3
Closing the Annual Conference 2023, we would like to thank all our stakeholders for their engagement and support for our shared mission to improve effective cancer treatment and empower patients. For those interested in our discussion during the last session,...